MedTrace Logo

Effect of Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women

NCT02592200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-01-05

No results posted yet for this study

Summary

The primary objective is to determine the change in frequency of complete spontaneous bowel movements (CSBMs) after 4 weeks of oral supplementation with Lactobacillus gasseri DSM 27123 in healthy adult women with functional constipation.

Conditions

  • Functional Constipation

Interventions

DIETARY_SUPPLEMENT

Lactobacillus gasseri DSM 27123

109 CFU (divided in two doses) per day for 28 days

DIETARY_SUPPLEMENT

Placebo

Two doses per day for 28 days

Sponsors & Collaborators

  • BioGaia AB

    lead INDUSTRY

Principal Investigators

  • Per Hellström, MD, PhD · Uppsala University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-05
Primary Completion
2016-06-21
Completion
2016-07-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02592200 on ClinicalTrials.gov